Our extensive early phase oncology experience enables us to guide your program through the intricacies inherent in dose-finding and dose-optimization, safety and proof-of-concept studies in a sick patient population. We look beyond first-in-human, and are active in a range of adaptive, basket and umbrella designs, as well as complex multi-arm platform design trials.
- Global network of specialist Phase I oncology sites
- Technology solutions for enhanced cohort planning and management
- Modeling and simulation of multiple datasets to identify optimal dose of novel targeted and immune therapies
- Laboratory services from Q2 Solutions for biomarker services, assay validation and development of companion diagnostics
